Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry.
Chunfeng DaiMuyin LiuZheng YangYouran LiYou ZhouDanbo LuYan XiaAo ChenChenguang LiHao LuYuxiang DaiJianying MaZhangwei ChenJuying QianJun-Bo GePublished in: BMC medicine (2024)
Chinese Clinical Trial Register ( https://www.chictr.org.cn ); Number: ChiCTR2300067274.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- clinical trial
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- low dose
- coronary artery disease
- st elevation myocardial infarction
- coronary artery bypass grafting
- cardiovascular events
- ultrasound guided
- lymph node metastasis
- phase ii
- open label
- study protocol
- atrial fibrillation
- double blind
- squamous cell carcinoma
- type diabetes
- cardiovascular disease
- left ventricular
- anti inflammatory drugs